Japan Tob (OTCMKTS:JAPAY) Sets New 1-Year High – Here’s Why

Japan Tob (OTCMKTS:JAPAY)’s share price hit a new 52-week high during mid-day trading on Friday. The company traded as high as $22.85 and last traded at $22.5840, with a volume of 523 shares changing hands. The stock had previously closed at $22.16.

Analysts Set New Price Targets

Separately, BTIG Research began coverage on shares of Japan Tob in a research report on Wednesday, July 22nd. They issued a “buy” rating on the stock. One equities research analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $17.00.

Japan Tob Trading Up 3.9%

The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.45 and a current ratio of 2.04. The firm has a market cap of $81.76 billion, a P/E ratio of 16.81, a P/E/G ratio of 1.46 and a beta of 0.28. The firm has a 50 day simple moving average of $21.88 and a 200 day simple moving average of $20.02.

Japan Tob (OTCMKTS:JAPAY) last announced its quarterly earnings results on Thursday, July 30th. The company reported $0.41 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.33 by $0.08. The firm had revenue of $6.67 billion during the quarter, compared to analysts’ expectations of $6.15 billion. On average, equities research analysts predict that Japan Tob will post 1.13 EPS for the current fiscal year.

Japan Tob Company Profile

Japan Tobacco Inc is a Japan-based company engaged primarily in the manufacture and sale of tobacco products. Its portfolio includes combustible cigarettes, heated tobacco products and other reduced-risk nicotine products marketed under brands such as Winston, MEVIUS, Camel and Ploom. The company serves consumers in Japan and international markets through its tobacco business.

In addition to tobacco, Japan Tobacco operates businesses in pharmaceuticals and processed foods. Its pharmaceutical activities focus on prescription medicines, while its food operations include products such as frozen foods, seasonings and processed food ingredients.